| Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis R Chakraborty, TM Burke, OA Hampton, DJ Zinn, KPH Lim, H Abhyankar, ... Blood, The Journal of the American Society of Hematology 128 (21), 2533-2537, 2016 | 158 | 2016 |
| CNS Langerhans cell histiocytosis: common hematopoietic origin for LCH‐associated neurodegeneration and mass lesions KL McClain, J Picarsic, R Chakraborty, D Zinn, H Lin, H Abhyankar, ... Cancer 124 (12), 2607-2620, 2018 | 113 | 2018 |
| A novel CMKLR1 small molecule antagonist suppresses CNS autoimmune inflammatory disease KL Graham, JV Zhang, S Lewén, TM Burke, T Dang, M Zoudilova, ... PloS one 9 (12), e112925, 2014 | 73 | 2014 |
| A chimeric antibody against ACKR3/CXCR7 in combination with TMZ activates immune responses and extends survival in mouse GBM models N Salazar, JC Carlson, K Huang, Y Zheng, C Oderup, J Gross, AD Jang, ... Molecular Therapy 26 (5), 1354-1365, 2018 | 57 | 2018 |
| Overcoming T-cell exhaustion in LCH: PD-1 blockade and targeted MAPK inhibition are synergistic in a mouse model of LCH A Sengal, J Velazquez, M Hahne, TM Burke, H Abhyankar, R Reyes, ... Blood, The Journal of the American Society of Hematology 137 (13), 1777-1791, 2021 | 35 | 2021 |
| Circulating CD1c+ myeloid dendritic cells are potential precursors to LCH lesion CD1a+CD207+ cells KPH Lim, P Milne, M Poidinger, K Duan, H Lin, N McGovern, H Abhyankar, ... Blood advances 4 (1), 87-99, 2020 | 33 | 2020 |
| Robust expansion of dendritic cells in vivo by hydrodynamic FLT3L-FC gene transfer H Tu, TM Burke, C Oderup, K Huang, K Wong, S Lewén, M LaJevic, ... Journal of immunological methods 413, 69-73, 2014 | 12 | 2014 |
| Anti TNF-α therapy in patients with relapsed and refractory Langerhans cell histiocytosis: a phase II study A Flores Legarreta, O Eckstein, TM Burke, KL McClain Pediatric Hematology and Oncology 35 (5-6), 362-368, 2018 | 7 | 2018 |
| Use of the Seraph® 100 Microbind® Affinity Blood Filter in an adolescent patient with disseminated adenoviral disease SM David S Li, Thomas M Burke, Jodi M Smith, Robyn C Reed, Daryl M Okamura Pediatr Nephrol, 2023 | 4* | 2023 |
| BRAF-V600E in Peripheral Mononuclear Cells and Microglia-like Brain Cells Suggest Hematopoietic Origin of Langerhans Cell Histiocytosis-Associated Neurodegeneration D Zinn, J Picarsic, R Chakraborty, H Lin, H Abhyankar, B Scull, A Shih, ... Blood 130, 2930, 2017 | 1 | 2017 |
| Elevated CSF osteopontin and peripheral blood cells with braf mutations in patients with langerhans cell histiocytosis-associated neurodegeneration D Zinn, J Picarsic, R Chakraborty, H Lin, H Abhyankar, B Scull, A Shih, ... PEDIATRIC BLOOD & CANCER 63, S37-S38, 2016 | 1 | 2016 |
| Use of the Seraph® 100 Microbind® Affinity Blood Filter in an Adolescent Patient with Disseminated Adenoviral Disease: SA-PO382 DS Li, TM Burke, JM Smith, DM Okamura, S Menon Journal of the American Society of Nephrology 34 (11S), 828, 2023 | | 2023 |
| LACK OF RESPONSES TO BLOCKING TUMOR NECROSIS FACTOR ALPHA IN LANGERHANS CELL HISTIOCYTOSIS LESIONS IN PATIENTS AND MICE T Burke, B Scull, H Abhyankar, O Eckstein, A Grom, K McClain, C Allen PEDIATRIC BLOOD & CANCER 67, S5-S5, 2020 | | 2020 |
| Blocking MAPK Activation and Immune Checkpoints Reverse Immune Dysfunction and Reduce Disease in a Mouse Model of LCH A Sengal, M Hahne, J Velasquez, H Abhyankar, T Burke, W Olea, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | | 2019 |
| CNS LANGERHANS CELL HISTIOCYTOSIS: COMMON HEMATOPOIETIC ORIGIN FOR LCH-ASSOCIATED NEURODEGENERATION AND MASS LESIONS K McClain, J Picarsic, R Chakraborty, D Zinn, H Lin, H Abhyankar, B Scull, ... PEDIATRIC BLOOD & CANCER 66, S30-S30, 2019 | | 2019 |
| CELL-SPECIFIC GENE EXPRESSION IN LANGERHANS CELL HISTIOCYTOSIS REVEALS DISTINCT PROFILES IN LESION CD207+ CELLS BASED ON BRAFV600E MUTATION H Lin, KPH Lim, H Abhyankar, R Chakraborty, B Scull, O Eckstein, D Zinn, ... PEDIATRIC BLOOD & CANCER 66, S25-S25, 2019 | | 2019 |
| EVALUATING ANTI-TNF-ALPHA THERAPY IN PATIENTS WITH RELAPSED AND REFRACTORY LANGERHANS CELL HISTIOCYTOSIS T Burke, A Legarreta, H Lin, B Scull, O Eckstein, K McClain, C Allen PEDIATRIC BLOOD & CANCER 66, S2-S3, 2019 | | 2019 |
| Evaluating Anti-TNF-Alpha Therapy in Patients with Relapsed and Refractory Langerhans Cell Histiocytosis T Burke, A Legarreta, H Lin, B Scull, OS Eckstein, KL McClain, CE Allen Blood, The Journal of the American Society of Hematology 132 (Supplement 1 …, 2018 | | 2018 |
| Hematopoietic Origin and Targets for Therapy in CNS Langerhans Cell Histiocytosis: BRAF-V600E in Blood and Brain and Response to BRAF Inhibition Suggest Hematopoeitic Origin of … O Eckstein, K McClain, J Picarsic, R Chakraborty, H Lin, H Abhyankar, ... PEDIATRIC BLOOD & CANCER 64, S6-S6, 2017 | | 2017 |
| Identification of Novel BRAF Alterations in LCH Using an Integrated Genomic Pipeline T Burke, R Chakraborty, O Hampton, D Zinn, B Scull, H Abhyankar, ... PEDIATRIC BLOOD & CANCER 63, S13-S14, 2016 | | 2016 |
Carl AllenProfessor of Pediatrics, Baylor College of Medicine在 txch.org 的电子邮件经过验证
